New Zealand vs South Africa: Number of isolates tested for ceftriaxone
New Zealand
861
in 2020
South Africa
316
in 2020
New Zealand rank
7th
South Africa rank
10th
Number of isolates tested for ceftriaxone over time
- New Zealand
- South Africa
How they compare
New Zealand currently reports 861 against 316 in South Africa, a difference of 545.
That makes New Zealand's figure about 2.7 times South Africa's.
Across all 5 years both countries report, New Zealand has been ahead every year.
New Zealand ranks 7th and South Africa ranks 10th of 52 countries.
New Zealand has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | New Zealand | South Africa | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 424.25 | 229 | 195.25 | New Zealand |
| 2020s | 861 | 316 | 545 | New Zealand |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher number of isolates tested for ceftriaxone, New Zealand or South Africa?
- New Zealand, at 861 against 316 in South Africa as of 2020.
- What is the difference in number of isolates tested for ceftriaxone between New Zealand and South Africa?
- 545, with New Zealand ahead.
- How many years of comparable data are there for New Zealand and South Africa?
- 5 years are reported by both, from 2011 to 2020.
- How do New Zealand and South Africa rank globally for number of isolates tested for ceftriaxone?
- New Zealand ranks 7th and South Africa ranks 10th of 52 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Number of isolates tested for ceftriaxone. Statizoid refreshes it automatically from the source and publishes the full history for both places.